The reporting of osteonecrosis of the jaw (ONJ) related to anticancer agents without known antiresorptive properties (non-antiresorptives), such as antiangiogenics, tyrosine kinase inhibitors, mammalian target of rapamycin inhibitors, immune checkpoint inhibitors, and cytotoxic chemotherapy is increasing.

Nicolatou-Galitis, O., Kouri, M., Papadopoulou, E., Vardas, E., Galiti, D., Epstein, J.B., et al. (2018). Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review. SUPPORTIVE CARE IN CANCER [10.1007/s00520-018-4501-x].

Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review

Campisi, Giuseppina;
2018-01-01

Abstract

The reporting of osteonecrosis of the jaw (ONJ) related to anticancer agents without known antiresorptive properties (non-antiresorptives), such as antiangiogenics, tyrosine kinase inhibitors, mammalian target of rapamycin inhibitors, immune checkpoint inhibitors, and cytotoxic chemotherapy is increasing.
2018
Nicolatou-Galitis, O., Kouri, M., Papadopoulou, E., Vardas, E., Galiti, D., Epstein, J.B., et al. (2018). Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review. SUPPORTIVE CARE IN CANCER [10.1007/s00520-018-4501-x].
File in questo prodotto:
File Dimensione Formato  
Nicolatou-Galitis2018_Article_OsteonecrosisOfTheJawRelatedTo.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 1.63 MB
Formato Adobe PDF
1.63 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/306069
Citazioni
  • ???jsp.display-item.citation.pmc??? 29
  • Scopus 73
  • ???jsp.display-item.citation.isi??? 66
social impact